Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01738061
Other study ID # MM-WHP-99
Secondary ID
Status Completed
Phase N/A
First received November 28, 2012
Last updated November 29, 2012
Start date January 2010
Est. completion date December 2010

Study information

Verified date November 2012
Source Asia University
Contact n/a
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Interventional

Clinical Trial Summary

The study was aimed to evaluate the effectiveness of a multidimensional worksite intervention program to reduce the severity of metabolic disorders in older workers in Taiwan.


Description:

The investigators conducted a quasi-experiment in older workers from three worksites in southern Taiwan.

- Qualified subjects were assigned to the intervention or the reference group according to their availability to take part in study activities.

- A researcher reviewed the health record and discussed with the subject about his/her health status.

- Subjects in the intervention group received lifestyle interventions. The activities included motivational presentations to increase awareness of own health problems and the role of lifestyle in the etiology of non-communicable chronic diseases.

- Subjects were organized into small groups to have biweekly meetings to share experiences, stimulate mutual encouragement and to overcome obstacles.

- Anthropometric and biochemical indicators were measured at baseline and endpoint (week 24).


Recruitment information / eligibility

Status Completed
Enrollment 108
Est. completion date December 2010
Est. primary completion date October 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 50 Years and older
Eligibility Inclusion Criteria:

- full-time worker

- aged 50 years or older

- willing to complete a screening questionnaire

- sign a study consent

Exclusion Criteria:

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Behavioral:
Multidimensional lifestyle intervention
Lecture series to increase awareness of the relationship of lifestyle to chronic diseases Individualized review and discussion to understand own health problems Biweekly group meetings to stimulate motivation and exchange ideas

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Asia University Department of Health, Executive Yuan, R.O.C. (Taiwan)

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in anthropometric and srum biochemical indicators. Body weight (BW), body height, waist circumference, Body mass index (BMI), arterial blood pressure (BP), serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and glycosylated hemoglobin (HbA1c) concentrations At baseline (week 0) and endpoint (week 24) of the intervention No
Secondary Lifestyle factors Physical activity, food consumption frequency and self-reported sleep and sedentary hours. At baseline (week 0) and endpoint (week 24) of the intervention No
See also
  Status Clinical Trial Phase
Completed NCT00546052 - A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331) Phase 3
Completed NCT02650674 - Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products N/A
Completed NCT00707746 - Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects Phase 2
Completed NCT02573103 - Air Pollution and Cardiovascular Disease
Not yet recruiting NCT06051461 - Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication N/A
Not yet recruiting NCT05013112 - Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT) N/A
Enrolling by invitation NCT04654000 - Rheopheresis as Adjuvant Treatment of Calciphylaxis N/A
Completed NCT01337141 - A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients N/A
Completed NCT00477594 - Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia Phase 2
Recruiting NCT03882580 - Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Active, not recruiting NCT01911091 - Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus) N/A
Completed NCT00607373 - Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia Phase 3
Completed NCT00362180 - Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration Phase 2
Completed NCT03873948 - Evaluation of Arginine in Periodontal and Cardiovascular Disease
Completed NCT02059993 - The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease N/A
Completed NCT06129578 - Plant Protein Supplementation Within a Healthy Lifestyle Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals N/A
Completed NCT06331572 - Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
Completed NCT05255718 - Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome N/A
Completed NCT00694109 - An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia Phase 3